Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on VALNEVA mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €2,28 on Euronext Paris, down 1,56% at the last update. This page lists the articles published on VALNEVA stock to track the share price, company announcements and any item likely to influence market perception.
Midday sees the Lyon-based biotech extending its downturn, as the SBF 120 also trends negatively. The stock is sinking into a technically fragile zone…
The Lyon-based biotech company experiences another session in the red, amidst a slightly bearish SBF 120. The stock is sinking below key technical lev…
The Lyon-based biotech specializing in vaccines continues to decline during the session, in an otherwise well-oriented SBF 120. The stock is sinking i…
The Lyon-based biotech specializing in vaccines declines during the session, amidst a slightly bullish SBF 120. The stock continues to operate in a fr…
Valneva Laboratories announced on Thursday its participation in several investor conferences in June 2026 in the United States and Europe. The managem…
Valneva laboratory regains momentum in the late afternoon, in a rising Parisian market. The stock erases some of its recent slide, after weeks marked …
The stock of the vaccine-specialized lab continues to decline this Wednesday at midday. Valneva is down 1.96% at €2.3980, while the SBF 120 index is u…
Valneva has released its Q1 2026 results, showing a 37% decrease in revenue and a net loss of €32.1 million, compared to a €9.2 million loss in Q1 202…
The stock of the Nantes-based vaccine specialist fell sharply this Tuesday morning to €2.63. Valneva is among the top 5 biggest losers in the SBF 120,…
Valneva, a vaccine-specialized laboratory, records the highest rebound in the SBF 120 on Monday midday, climbing to €2.68, while the broader index dro…
